Hi All,
I was hoping someone in Biotech ER/VC/IB could share a model they used to forecast the IS for a pre-revenue company. Preferably one where there is a revenue build with # of patients, prevalence, adoption curve etc. included. This would be a massive help. Thanks in advance.
| +268 | UBS Tech MD hires Son (from no-name college) as an Intern | 49 | 39m |
| +166 | WTF IS THIS COMPETITON | 59 | 16h |
| +161 | Mayday, Mayday: Key UBS Leaders (Former Barclays MDs) Abandoning Ship | 28 | 3d |
| +118 | Is banking in the south more sustainable? | 28 | 9h |
| +94 | The Intern Starter Pack | 16 | 5m |
| +75 | Current State of the League Tables | 28 | 14h |
| +51 | [Official] 2026 IB Analyst Bonus Megathread (with 2025 Consolidated Pay and Perks/Benefits) | 9 | 8h |
| +49 | Perella Weinberg to Cut 10% of Workforce, Including Partners | 31 | 1d |
| +40 | UBS Groups Ranked by Future Outlook | 20 | 1d |
| +32 | PWP Layoffs????? | 18 | 3d |
Career Resources
Get instant access to lessons taught by experienced private equity pros and bulge bracket investment bankers including financial statement modeling, DCF, M&A, LBO, Comps and Excel Modeling.
bump
Pull an equity research report and copy their build.
SGMO, QURE, ONCE, GBT all have similar builds to what you describe.
Eveniet nihil aspernatur sint repudiandae eos. Et voluptate in reprehenderit. Quibusdam in accusantium dolorem. Excepturi non qui at minima necessitatibus voluptatem. Odio sit nihil dignissimos unde. Dolor vel qui quibusdam et porro.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...